Eva van Grinsven1, Anouk Smits1, Emma van Kessel1, Mathijs Raemaekers1, Edward de Haan2, Irene Huenges Wajer1,3, Veerle Ruijters1, Marielle Philippens4, Joost Verhoeff4, Pierre Robe1, Tom Snijders1, and Martine van Zandvoort1,3
1Department of Neurology & Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, Netherlands, 2Department of Psychology, University of Amsterdam, Amsterdam, Netherlands, 3Department of Experimental Psychology and Helmholtz Institute, Utrecht University, Utrecht, Netherlands, 4Department of Radiotherapy, University Medical Center Utrecht, Utrecht, Netherlands
Synopsis
While
lesion-symptom mapping can inform on which brain regions are crucial for a
given behavior, it is still unclear whether different lesion etiologies show comparable
structure-function relationships. In this study, support-vector regression lesion-symptom
maps were compared between a glioma and stroke population. As expected, pathology
distinct coverage patterns in the brain were found and there were more and larger
significant voxel clusters in the tumor group. Our preliminary conclusion is
that despite some differences in lesion-symptom associations in comparing a
tumor and stroke population, these two populations can provide complementary
information regarding involvement of brain regions for given cognitive tasks.
Introduction
Lesion-symptom
mapping is a key tool in understanding the relationship between brain
structures and behavior and is applied by both researchers and clinicians on a
daily basis to assess and predict the functional outcomes after a brain lesion.1 However, the
behavioral consequences of lesions from different etiologies may vary as a
result of how they affect the brain. For example, ischemic stroke causes
relatively immediate cell death within the affected brain area, whereas neural
activity can persist after infiltration by a tumor.2 Additionally,
lesion distribution differs between etiologies; stroke most often occurs in
subcortical areas in the territory of the middle cerebral artery,3 while brain
tumors often involve both subcortical and cortical structures in the frontotemporoinsular
areas.4 This
a-priori location bias is also incorporated in most of the current
lesion-symptom knowledge, since this is most often based on a stroke
population. Possibly, combining two populations in lesion-symptom mapping can
partly circumvent this bias and lead to new insights. To assess whether lesion-symptom
maps derived from different populations can provide converging evidence, the
current study directly compared lesion-symptom maps between a stroke and a
tumor population.Methods
Data from two different studies were combined. The
tumor data were collected in a single-center consecutive study cohort of
treatment-naive diffuse glioma (WHO grade 2-4) patients who underwent awake
brain surgery between January 2010 and July 2019. The stroke data was gathered
as part of a multi-center prospective cohort study in adult patients
administered to the hospital between September 2015 and December 2019. Both
patient populations had neuropsychological testing and a MRI performed,
pre-operatively for the tumor population or within three months after stroke. The
administered neuropsychological tests are internationally widely used,
standardized psychometric tasks for assessing neurocognitive deficits in the
major neurocognitive domains. Raw scores on each test were transformed into
z-scores based on published normative data. If applicable, corrections were
made based on sex, age group and/or educational level. The tumor and infarct
lesions (defined as hyperintense signal abnormalities) were delineated on T2
FLAIR images using the Smartbrush implemented in the iPlan v3.0 software5 or the ITK-snap
software,6 respectively. Each
individual’s FLAIR and binary lesion mask was then normalized to the MNI
template using the unified segmentation-normalization algorithm implemented in
SPM12.7 For each cognitive
task multivariate lesion-symptom mapping analyses were performed using the
updated version of the support-vector regression lesion-symptom mapping toolbox
running under Matlab2019a,8 which is a
multivariate regression algorithm based on machine learning.9,10 A lesion threshold
of three patients was applied to restrict the analysis to those voxels with
reasonable statistical power.1 To test the
significance of the beta values permutation testing was used with 1.000
permutations and a voxelwise threshold of p<.005. Lesion volume was
corrected for by regressing it on both the lesion and behavioral data. The
AALCAT atlas was superimposed on the results to relate significant voxels to
brain regions.Preliminary Results & Discussion
196 tumor
patients and 146 first-ever cerebral stroke patients were included for the analysis in the
current study. As expected, the areas covered by the tumor and stroke lesions
showed overlap, but also significant differences in coverage (Figure 1).
Despite this difference in lesion distribution, the cognitive pattern did not
vary to a great extent (Figure 2). When looking at the lesion-symptom maps, distinct
cognitive tasks (i.c. Figure 3 and 4) are associated with distinct
neuroanatomical patterns in both groups and follow the expected lateralization
based on previous literature. Nonetheless, lesion-symptom maps from the tumor
group are not identical to those from the stroke group, with some areas
implicated in the tumor, but not in the stroke group or vice versa. Additionally,
larger clusters of voxels covering more brain areas are significant in the
tumor compared to the stroke group for all eleven cognitive tasks (max. 40
brain areas versus 23). These differences could be explained by several
factors. Firstly, not all regions implicated by tumor were part of the lesion
coverage in the stroke group, which hinders comparison. Secondly, in the tumor
population both tumor and tumor surrounding edema were part of the lesion.
Also, diffuse gliomas, specifically lower grade gliomas, infiltrate or displace
healthy brain parenchyma without necessarily damaging this tissue. Thus, this
parenchyma could still be functional even though it is adversely affected by
the tumor presence. Alternatively, tumors can release toxins that may act at a
distance and alter functions in areas not directly altered by their growth. Speculatively, the areas
indicated in the stroke maps might represent crucial brain areas for that
function, while for the tumor the areas indicate involvement.Conclusion
Lesion-symptom maps based on different
etiologies indicated divergent structure-function patterns, with more and
larger significant clusters in the tumor group. This could partly be explained
by a difference in lesion coverage of the brain and how the brain is affected
by either a tumor or stroke lesion. Despite these considerable differences, for
both populations cognitively distinct tasks were associated with distinct
neuroanatomical brain regions, with the brain regions corroborating those found
by previous lesion studies in these populations. Therefore, our preliminary
conclusion is that these two populations can provide complementary information
regarding involvement of brain regions in different cognitive processes.Acknowledgements
No acknowledgement found.References
1. Karnath HO, Sperber C, Rorden C. Mapping human brain lesions and their functional consequences. Neuroimage. 2018;165:180-189.
2. Krainik A, Lehéricy S, Duffau H, et al. Postoperative speech disorder after medial frontal surgery. Neurology. 2003;60(4):587-594.
3. Sperber C, Karnath HO. Topography of acute stroke in a sample of 439 right brain damaged patients. NeuroImage Clin. 2016;10:124-128.
4. Kleihues P, Burger PC, Aldape K, et al. WHO Classification of Tumors of the Central Nervous System. World Heal Organ Classif Tumours. Published online 2007:33-49.
5. BrainLab AG, Feldkirchen, Germany.
6. Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116-1128.
7. Rorden C, Bonilha L, Fridriksson J, Bender B, Karnath HO. Age-specific CT and MRI templates for spatial normalization. Neuroimage. 2012;61(4):957-965.
8. The MathWorks, Inc., Natick, Massachusetts, United States.
9. Zhang Y, Kimberg DY, Coslett HB, Schwartz MF, Wang Z. Multivariate lesionâsymptom mapping using support vector regression. Hum Brain Mapp. 2014;35:5861-5876.
10. DeMarco AT, Turkeltaub PE. A multivariate lesion symptom mapping toolbox and examination of lesion-volume biases and correction methods in lesion-symptom mapping. Hum Brain Mapp. 2018;39(11):4169-4182.